Click here to view the United Healthcare (UHC) Medical Policy Updates » November 2024 United…
Humana Pharmacy Policy Updates – June 2018
Click here to view the Humana Pharmacy Policy Updates »
June 2018 Pharmacy Policy Updates:
- Actemra® (tocilizumab) Subcutaneous
- Actemra® (tocilizumab) Subcutaneous
- Angiotensin Blocking Agents
- Angiotensin Blocking Agents
- Appropriate Site of Care for Injectable Drugs
- Aptiom® (eslicarbazepine acetate)
- Basaglar® (insulin glargine)
- Basaglar® (insulin glargine)
- Dacogen® (decitabine)
- Dipeptidyl Peptidase‐4 (DPP‐4) Inhibitors
- Duavee (conjugated estrogens/bazedoxifene) tablets
- Duavee® (conjugated estrogens/bazedoxifene tablet)
- Emend® IV (fosaprepitant)
- Gene Expression Profiling
- Gleevec® (imatinib mesylate)
- GLP‐1 Analogs
- GLP‐1 Analogs
- Glucagon™ Emergency Kit for Low Blood Sugar
- Juxtapid® (lomitapide)
- Kevzara® (sarilumab)
- Kevzara® (sarilumab)
- Kymriah™ (tisagenlecleucel)
- Kynamro® (mipomersen)
- Leukine® (sargramostim/GM‐CSF)
- Lovaza® (omega‐3‐acid ethyl esters)
- Luzu® (luliconazole)
- Mircera® (methoxy polyethylene glycol‐epoetin beta)
- Molindone hydrochloride
- Naftin® Gel (naftifine)
- Negative Pressure Wound Therapy (NPWT)
- Neulasta® (pegfilgrastim)
- Neupogen® (filgrastim)
- Neupro® (rotigotine)
- Nuvigil® (armodafinil)
- Opdivo® (nivolumab)
- Oral Acne Antibiotics
- Osmolex™ (amantadine)
- Oxaydo™ (oxycodone HCl)
- Oxycontin® (oxycodone hydrochloride controlled release)
- Oxycontin® (oxycodone hydrochloride controlled release)
- Pentasa® (mesalamine)
- Phoslyra (calcium acetate oral solution)
- Phoslyra (calcium acetate oral solution)
- Phosphate Binding Agents
- Praluent® (alirocumab)
- Qudexy XR®, Trokendi XR® (extended release topiramate)
- Qudexy XR®, Trokendi XR® (topiramate extended release)
- Rituxan Hycela™ (rituximab/hyaluronidase)
- Sabril® (vigabatrin)
- SGLT2 Inhibitors
- Soolantra® (ivermectin 1% topical cream)
- Spritam® (levetiracetam)
- Stivarga® (regorafenib)
- Taclonex® (calcipotriene and betamethasone dipropionate)
- Thalomid® (thalidomide)
- Thiazolidinediones (TZDs)
- Topical Antifungals
- Topical Rosacea Products
- Tramadol hydrochloride extended release (ConZip, generic Conzip, generic Ryzolt ER, Ultram ER)
- Tymlos™ (abaloparatide) subcutaneous injection
- Ulcerative Colitis Agents (Asacol® HD, Delzicol®, Dipentum®, mesalamine delayed‐release)
- Varubi® (rolapitant)
- Vidaza® (azacitidine
- Xadago® (safinamide)
- Xatmep™ (methotrexate) oral solution
- Xenazine® (tetrabenazine)
- Xyrem® (sodium oxybate)
- Yosprala® (aspirin and omeprazole)
- Zarxio® (filgrastim‐sndz)
- Zejula™ (niraparib)
Click here to view the Humana Pharmacy Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.